The coronavirus was spreading rapidly, workplaces were locked down, and Connecticut could barely turn around a virus test result in less than two weeks.
It was April of 2020. The state was desperate for help from any laboratory that could process COVID tests quickly. Much of the laboratory space at Sema4, a Stamford-based healthcare technology startup, was sitting idle, its genomic data analysis business largely suspended by the pandemic. So Sema4 pivoted.